Literature DB >> 14691703

The Lap-Band system in the United States: one surgeon's experience with 271 patients.

H Spivak1, F Anwar, S Burton, C Guerrero, A Onn.   

Abstract

BACKGROUND: The LAP-BAND system is considered an important bariatric surgery procedure in many countries and is rapidly gaining acceptance in the United States. Outcomes data emerging in the United States parallel European and Australian experience. The purpose of this study was to examine our experience with this procedure in the United States.
METHODS: Between November 2000 and September 2002, 271 patients (236 women) underwent LAP-BAND system placement. The mean age of patients was 40 years (18-63); preoperative mean body weight was 125 kg (93-192). Surgeries were performed using either the two-step (pars flaccida to perigastric) or the pars flaccida technique with three (1.1%) conversions to open procedures. Mean operative time was 42 min (23-86); average hospital stay was 1 day (4 h to 7 days).
RESULTS: The mean body mass index (BMI) decreased from a baseline of 45.3 kg/m(2) (35-68) to 41.9 ( n = 178), 39.5 ( n = 101), 38.4 (n = 81), 36.5 (n = 72), 35.9 (n = 51), and 35.1 (n = 21) kg/m(2) at 3, 6, 9, 12, 18, and 24 months, respectively, after surgery. Mean excess weight loss was 40% at 12 months and 43% at 24 months. As patients lost weight, comorbid conditions improved. No deaths occurred, no bands had to be removed, and postoperative complications were minor: 20 (7.3%) access port problems, 18 (6.6%) gastric pouch dilatations, five (1.8%) gastric slippages, and five (1.8%) stoma obstructions. All were managed conservatively or repaired laparoscopically using the original bands. Additional complications included four cases of pneumonia and one case of pulmonary embolism. One patient required reoperation because of trocar site bleeding.
CONCLUSIONS: The LAP-BAND system is a safe and effective bariatric procedure leading to considerable weight loss and reduction in comorbidity.

Entities:  

Mesh:

Year:  2003        PMID: 14691703     DOI: 10.1007/s00464-003-8825-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

Review 1.  Avoiding postoperative complications with the LAP-BAND system.

Authors:  Hadar Spivak; Franco Favretti
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

2.  Laparoscopic gastric banding with Lap-Band for morbid obesity: two-step technique may improve outcome.

Authors:  M Rubin; S Benchetrit; H Lustigman; S Lelcuk; H Spivak
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

3.  Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity.

Authors:  Eric J DeMaria; Harvey J Sugerman; John M Kellum; Jill G Meador; Luke G Wolfe
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

4.  Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up.

Authors:  A C Wittgrove; G W Clark
Journal:  Obes Surg       Date:  2000-06       Impact factor: 4.129

5.  Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution.

Authors:  J Dargent
Journal:  Obes Surg       Date:  1999-10       Impact factor: 4.129

6.  Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity.

Authors:  P E O'Brien; W A Brown; A Smith; P J McMurrick; M Stephens
Journal:  Br J Surg       Date:  1999-01       Impact factor: 6.939

7.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

8.  Laparoscopic gastric banding: a minimally invasive surgical treatment for morbid obesity: prospective study of 500 consecutive patients.

Authors:  Franck Zinzindohoue; Jean-Marc Chevallier; Richard Douard; Nejib Elian; Jean-Marc Ferraz; Jean-Philippe Blanche; Jean-Louis Berta; Jean-Jacques Altman; Denis Safran; Paul-Henri Cugnenc
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

9.  Laparoscopic management of lap-band slippage.

Authors:  Hadar Spivak; Moshe Rubin
Journal:  Obes Surg       Date:  2003-02       Impact factor: 4.129

Review 10.  Medical and surgical options in the treatment of severe obesity.

Authors:  Barry L Fisher; Philip Schauer
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

View more
  6 in total

1.  Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity.

Authors:  T H Kim; A Daud; A O Ude; M DiGiorgi; L Olivero-Rivera; B Schrope; D Davis; W B Inabnet; M Bessler
Journal:  Surg Endosc       Date:  2005-12-06       Impact factor: 4.584

Review 2.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Radiological features of complications of laparoscopic adjustable gastric banding.

Authors:  T Moey; W C G Peh; W Peh; M J Clarke; M Clarke; N Dubey; D Niraj; A Cheng
Journal:  Radiol Med       Date:  2009-06-23       Impact factor: 3.469

4.  Laparoscopic adjustable gastric banding versus laparoscopic gastric bypass for morbid obesity: a single-institution comparison study of early results.

Authors:  Jay C Jan; Dennis Hong; Natasha Pereira; Emma J Patterson
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

5.  Benchmarking hospital outcomes for laparoscopic adjustable gastric banding.

Authors:  M A Edwards; R Grinbaum; B E Schneider; A Walsh; J Ellsmere; D B Jones
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

Review 6.  Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass.

Authors:  Jane Garb; Garry Welch; Sofija Zagarins; Jay Kuhn; John Romanelli
Journal:  Obes Surg       Date:  2009-08-05       Impact factor: 4.129

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.